WYMM Tour: Stockholm
07 March 2024, 10:00 - 16:45 CET - Stockholm, Sweden
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Thursday 7th March 2024 in Stockholm to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
10:00 – 20:00 hrs CET | Agenda (subject to change) | |
|---|---|---|
10:00 – 10:45 hrs | Registration, breakfast and networking | |
10:45 – 11:10 hrs | What you're missing matters: Catching the unnoticed | Tonya McSherry, Oxford Nanopore Technologies |
11:10 – 11:35 hrs | Large-scale methylation studies using Oxford Nanopore sequencing | Brynja Sigurpálsdóttir, deCODE genetics |
11:35 – 12:00 hrs | Leveraging long read sequencing to resolve complex structural variants in cancer genomes | Joachim Weischenfeld, Biotech Research & Innovation Centre (BRIC), University of Copenhagen |
12:00 – 13:15 hrs | Lunch | |
13:15 – 13:40 hrs | Oxford Nanopore Technologies bioinformatics update | Stephen Rudd, Oxford Nanopore Technologies |
13:40 – 14:05 hrs | Long-read DNA sequencing to identify disease-causing genetic variation | Anna Lindstrand, Karolinska University Hospital |
14:05– 14:30 hrs | Characterisation of novel splicing events across brain tissues and during development | Wilfried Haerty, Earlham Institute |
14:30 – 15:30 hrs | Networking session | |
15:30 – 16:05 hrs | Panel discussion: The future of nanopore sequencing in clinical research | Moderated by Chris Swagell, Oxford Nanopore Technologies |
16:05 – 16:35 hrs | Rapid molecular diagnostics using nanopore sequencing in patients with CNS tumors | Henning Leske, Department of Pathology, Rikshospitalet |
16:35 – 16:45 hrs | Closing remarks | Oxford Nanopore Technologies |
16:45 – 20:00 hrs | Drinks reception |
Speakers
)
Large-scale methylation studies using Oxford Nanopore sequencing
Brynja Sigurpálsdóttir, deCODE
I'm a research associate at deCODE genetics, concurrently pursuing my PhD at Reykjavík University. M...
)
Leveraging long read sequencing to resolve complex structural variants in cancer genomes
Joachim Weischenfeld, BRIC, University of Copenhagen
Affiliation: BRIC/Finsen Laboratory, Rigshospitalet and BRIC, University of Copenhagen Short Bio: P...
)
Long-read DNA sequencing to identify disease-causing genetic variation
Anna Lindstrand, Karolinska University Hospital
Prof. Anna Lindstrand, a Clinical Genetics consultant and Director at Karolinska University Hospital...
)
Rapid molecular diagnostics using nanopore sequencing in patients with CNS tumors
Henning Leske, Rikshospitalet
After studying medicine at the LMU in Munich i started my specialization i Neuropathology in Zurich,...
)
Characterisation of novel splicing events across brain tissues and during development
Wilfried Haerty, Earlham Institute
I completed my PhD in 2004 (University Paris VI), followed by postdocs at McMaster University (Hamil...